FILE:AGN/AGN-8K-20040928195107.txt.gz
EVENTS:	Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
TEXT:
ITEM: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
Table of Contents
     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Table of Contents
     This amendment updates the disclosure to Item 5 of the Current Report on Form 8-K filed by Allergan, Inc. ("Allergan" or the "Company") on July 28, 2004.
Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
     On July 28, 2004, Allergan announced that Trevor M. Jones, Ph.D. was appointed to its Board of Directors as a Class II director. On September 26, 2004, the Allergan Board of Directors voted to modify the class of director and term for Professor Jones. Professor Jones will now serve as a Class I director and his term will expire at Allergan's Annual Meeting of Stockholders in 2005.
Table of Contents
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


